Schedule a call with a peer mentor
JENNIFER: Hi, I'm Jennifer, and I'm a Shire ambassador and a You, Me and HAE mentor. The You, Me and HAE mentor program is a great opportunity to be able to talk to someone on the phone that has HAE just like you do.
Some of the benefits of the mentor program is basically getting to speak to someone else who's gone through the same things that you have; is treating with FIRAZYR, something that you're potentially looking into; and also just knowing someone else that's been there, can kind of relate to you on a personal level and just make you feel better about taking the next step and learning about more treatments.
It's really important to share my experience with living with HAE because there's so few of us out there. One of the times that I felt I really helped someone on a mentor phone call was a woman who had never spoken to anyone outside of her family that had HAE. She was a little nervous about looking for treatment, and she just needed someone else to relate to and talk to, and just kind of going over my own experiences with her really made her feel at ease, and it made me feel really good to help her.
I hope you'll register today to speak with a mentor soon. You can call Monday through Friday, 8:30 a.m. to 8:00 p.m. Eastern Standard Time. 866-888-0660, or visit firazyr.com today to register to speak with a mentor.
NARRATOR: Indication: FIRAZYR® (icatibant injection) is a medicine used to treat acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
Important Safety Information: Laryngeal attacks can become life threatening. If you have an HAE attack of the throat (laryngeal attack), inject FIRAZYR and then go to the nearest hospital emergency room right away.
The most common side effects of FIRAZYR include:
- redness, bruising, swelling, warmth, burning, itching, irritation, hives, numbness, pressure, or pain at the injection site
- too much of an enzyme called transaminase in your blood
The safety profile of FIRAZYR in patients who gave themselves the injection was similar to that in patients who had the injection given by a healthcare professional.
Tell your healthcare provider if you have any other medical conditions, if you are breastfeeding or plan to breastfeed, or if you are pregnant or planning to become pregnant. FIRAZYR has not been evaluated in pregnant or nursing women. You and your healthcare provider will decide if FIRAZYR is right for you.
If your symptoms continue or come back, you may repeat your FIRAZYR injection at least 6 hours apart. Do not use more than 3 doses of FIRAZYR in a 24-hour period.
Tiredness, drowsiness, and dizziness have been reported following the use of FIRAZYR. If this occurs, do not drive a car, use machinery, or do anything that needs you to be alert.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. For more information about FIRAZYR, ask your healthcare provider. For further information, please see the full Prescribing Information, including Patient Information. You can also call Shire at 1-866-888-0660.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.